Amp Capital Investors LTD Repligen Corp Transaction History

Amp Capital Investors LTD

  • $0
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $706,621 - $868,957
-2,854 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $29,994 - $49,928
154 Added 5.7%
2,854 $825,000
Q4 2020

Feb 12, 2021
BUY
$148.08 - $206.57 $399,816 - $557,739
2,700 New
2,700 $511,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.11B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email